Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups
Background and Aim The metabolic syndrome (MetS) and each of its components are strongly associated with non‐alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory fac...
        Saved in:
      
    
          | Published in | Journal of gastroenterology and hepatology Vol. 28; no. 4; pp. 664 - 670 | 
|---|---|
| Main Authors | , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Australia
          Blackwell Publishing Ltd
    
        01.04.2013
     | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0815-9319 1440-1746 1440-1746  | 
| DOI | 10.1111/jgh.12106 | 
Cover
| Abstract | Background and Aim
The metabolic syndrome (MetS) and each of its components are strongly associated with non‐alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS.
Methods
We analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988–1994). NAFLD was defined by increased liver fat measured by ultrasonography.
Results
MetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high‐density lipoprotein ratio, and mean arterial pressure) showed excellent goodness‐of‐fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non‐Hispanic Blacks and Mexican Americans.
Conclusions
The MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study. | 
    
|---|---|
| AbstractList | The metabolic syndrome (MetS) and each of its components are strongly associated with non-alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS.
We analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988-1994). NAFLD was defined by increased liver fat measured by ultrasonography.
MetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high-density lipoprotein ratio, and mean arterial pressure) showed excellent goodness-of-fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non-Hispanic Blacks and Mexican Americans.
The MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study. Background and Aim The metabolic syndrome (MetS) and each of its components are strongly associated with non‐alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS. Methods We analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988–1994). NAFLD was defined by increased liver fat measured by ultrasonography. Results MetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high‐density lipoprotein ratio, and mean arterial pressure) showed excellent goodness‐of‐fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non‐Hispanic Blacks and Mexican Americans. Conclusions The MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study. The metabolic syndrome (MetS) and each of its components are strongly associated with non-alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS.BACKGROUND AND AIMThe metabolic syndrome (MetS) and each of its components are strongly associated with non-alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS.We analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988-1994). NAFLD was defined by increased liver fat measured by ultrasonography.METHODSWe analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988-1994). NAFLD was defined by increased liver fat measured by ultrasonography.MetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high-density lipoprotein ratio, and mean arterial pressure) showed excellent goodness-of-fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non-Hispanic Blacks and Mexican Americans.RESULTSMetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high-density lipoprotein ratio, and mean arterial pressure) showed excellent goodness-of-fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non-Hispanic Blacks and Mexican Americans.The MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study.CONCLUSIONSThe MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study.  | 
    
| Author | Smits, Mark M Utzschneider, Kristina M Boyko, Edward J Ioannou, George N  | 
    
| Author_xml | – sequence: 1 givenname: Mark M surname: Smits fullname: Smits, Mark M organization: Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA – sequence: 2 givenname: George N surname: Ioannou fullname: Ioannou, George N organization: Division of Gastroenterology, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Washington, Seattle, USA – sequence: 3 givenname: Edward J surname: Boyko fullname: Boyko, Edward J organization: Epidemiologic Research and Information Center, VA Puget Sound Health Care System and University of Washington, Washington, Seattle, USA – sequence: 4 givenname: Kristina M surname: Utzschneider fullname: Utzschneider, Kristina M email: kutzschn@u.washington.edu organization: Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System and University of Washington, Washington, Seattle, USA  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23286209$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNp9kU1PFTEUhhuDkQuy8A-YLmUx0E6n8-HOgF4k5GIUgnHTdDpnuMVOe2k76PwO_7DlXmBhgl2cbp7nTc55d9CWdRYQekPJAU3v8OZ6eUBzSsoXaEaLgmS0KsotNCM15VnDaLONdkK4IYQUpOKv0HbO8rrMSTNDfxbOZtIot3RGK9zLGCds9B143OkAMgCWAUuLte1gBWnYiAdpdQ8hyqidxa7HcQl4gCjbdUiYbOfdAO_xVwijieEekfjyG7ZrQxocRn8HUwpNqgfAEJc2mdfejavwGr3spQmw9_DvostPHy-OTrKz8_nnow9nmSrypsxYWTOpesU6znroFJdtzQitea1ayqnKqSR1o5qG8bwoOWWMEaCk40TylpcV20XvNrkr727HtI8YdFBgjLTgxiAoywktq7oiCX37gI7tAJ1YeT1IP4nHQyZgfwMo70Lw0D8hlIj7kkQqSaxLSuzhP6zSm1tGL7X5n_FLG5iejxan85NHI9sYOkT4_WRI_1OkzSsurhZz8X1xRX4c81Pxhf0FIr6y3Q | 
    
| CitedBy_id | crossref_primary_10_1111_eci_14368 crossref_primary_10_1007_s11033_016_4058_z crossref_primary_10_1016_j_jhep_2017_11_012 crossref_primary_10_1136_heartjnl_2013_305099 crossref_primary_10_1016_j_nutres_2014_04_001 crossref_primary_10_1186_1475_2891_12_96 crossref_primary_10_1093_bmb_ldw031 crossref_primary_10_1186_s12944_023_01867_3 crossref_primary_10_1186_s12876_018_0906_8 crossref_primary_10_1016_j_cld_2015_10_002 crossref_primary_10_1016_j_jhepr_2023_100964 crossref_primary_10_1111_jgh_15154 crossref_primary_10_1152_ajpendo_00207_2020 crossref_primary_10_3390_nu13030856 crossref_primary_10_1111_liv_13622 crossref_primary_10_3390_cells9071638 crossref_primary_10_1016_j_ecl_2013_09_009 crossref_primary_10_1097_MD_0000000000010214 crossref_primary_10_1111_liv_13860 crossref_primary_10_1590_0001_3765201720160394 crossref_primary_10_1097_MD_0000000000038530 crossref_primary_10_1136_bmjopen_2015_008204 crossref_primary_10_1016_j_amjms_2020_06_020 crossref_primary_10_1080_07853890_2021_1943514 crossref_primary_10_1002_oby_20624 crossref_primary_10_3390_ijms17030367 crossref_primary_10_1007_s10620_016_4143_0 crossref_primary_10_1111_jgh_12432 crossref_primary_10_1007_s11695_021_05797_w crossref_primary_10_1007_s40265_015_0437_3 crossref_primary_10_1007_s00345_014_1392_4 crossref_primary_10_1155_2018_8597897 crossref_primary_10_1016_j_dld_2021_05_022 crossref_primary_10_2139_ssrn_4118388 crossref_primary_10_1016_j_clnesp_2020_04_004 crossref_primary_10_33590_emj_10310531 crossref_primary_10_1016_j_jcmgh_2018_09_017 crossref_primary_10_1080_17474124_2017_1355731 crossref_primary_10_1186_s12902_021_00719_4 crossref_primary_10_3748_wjg_v22_i32_7236 crossref_primary_10_1007_s11596_022_2573_9 crossref_primary_10_1016_j_jacl_2016_09_007 crossref_primary_10_54307_2024_NWMJ_95 crossref_primary_10_1080_07315724_2018_1443292 crossref_primary_10_1002_hep_27242 crossref_primary_10_1016_j_juro_2018_03_135 crossref_primary_10_1111_jgh_12935 crossref_primary_10_3390_app132111747 crossref_primary_10_1136_bmjopen_2022_070431 crossref_primary_10_1371_journal_pone_0096651 crossref_primary_10_1002_oby_23438 crossref_primary_10_1111_1751_2980_12341 crossref_primary_10_15436_2378_6841_18_1561 crossref_primary_10_1186_s12902_022_00993_w crossref_primary_10_14260_jemds_2016_166 crossref_primary_10_1016_j_cca_2016_07_003 crossref_primary_10_4254_wjh_v6_i5_274 crossref_primary_10_1111_resp_13127 crossref_primary_10_1080_00325481_2019_1546532 crossref_primary_10_3390_nu9060540 crossref_primary_10_3389_fpsyt_2024_1343427 crossref_primary_10_33590_emjhepatol_10311541 crossref_primary_10_1038_nature13478 crossref_primary_10_1586_17474124_2015_1003209 crossref_primary_10_1186_s12876_023_02864_7 crossref_primary_10_1016_j_pan_2020_08_011 crossref_primary_10_1038_srep27034 crossref_primary_10_1007_s00774_015_0687_x crossref_primary_10_1111_apt_14327 crossref_primary_10_1093_function_zqab001 crossref_primary_10_1002_mgg3_168 crossref_primary_10_1097_MCG_0000000000001229 crossref_primary_10_1016_j_cgh_2015_05_001 crossref_primary_10_1097_MD_0000000000000907 crossref_primary_10_1016_j_cld_2017_08_008 crossref_primary_10_1097_MEG_0000000000000598 crossref_primary_10_1016_j_cld_2017_08_006 crossref_primary_10_1371_journal_pone_0165970 crossref_primary_10_3748_wjg_v20_i47_17839 crossref_primary_10_1089_bari_2016_0018 crossref_primary_10_1016_j_cld_2017_08_001 crossref_primary_10_1016_j_jhep_2023_03_017 crossref_primary_10_1074_jbc_M116_728949 crossref_primary_10_3748_wjg_v21_i14_4103 crossref_primary_10_1007_s10620_015_3983_3 crossref_primary_10_1042_CS20150308 crossref_primary_10_1186_s40364_017_0096_5 crossref_primary_10_1016_j_dld_2014_09_020 crossref_primary_10_1111_obr_13481 crossref_primary_10_1152_ajpendo_00345_2017 crossref_primary_10_1007_s11894_016_0485_1 crossref_primary_10_1002_cam4_2777 crossref_primary_10_1097_HEP_0000000000000323 crossref_primary_10_1111_bju_14753 crossref_primary_10_1016_j_redox_2016_09_002 crossref_primary_10_3390_cells11203227 crossref_primary_10_1016_j_jpeds_2020_01_031 crossref_primary_10_11569_wcjd_v30_i11_465 crossref_primary_10_3390_cimb44050129 crossref_primary_10_1038_nrgastro_2017_109 crossref_primary_10_3803_EnM_2019_34_2_179 crossref_primary_10_3390_ijms22084241 crossref_primary_10_1016_j_gene_2024_148660 crossref_primary_10_12688_wellcomeopenres_12199_1 crossref_primary_10_1186_s40168_021_01125_7  | 
    
| Cites_doi | 10.1002/hep.24726 10.1016/j.jacc.2006.09.032 10.1016/j.metabol.2011.09.003 10.7326/0003-4819-143-10-200511150-00009 10.1161/CIRCULATIONAHA.105.559633 10.1016/j.cld.2009.02.009 10.2337/dc09-2049 10.1159/000090173 10.2337/diabetes.50.8.1844 10.1111/j.1440-1746.2010.06542.x 10.1016/j.atherosclerosis.2006.12.018 10.2337/diacare.26.11.3153 10.1007/s00125-007-0651-y 10.2337/diacare.27.5.1182 10.1161/01.ATV.17.11.2413 10.2337/diacare.29.01.06.dc05-0862 10.1056/NEJM199909023411002 10.3748/wjg.14.185 10.1037/10694-000 10.1111/j.1751-2980.2011.00487.x 10.1002/hep.24452 10.1001/jama.287.3.356 10.2337/diab.45.6.742 10.1002/hep.20466 10.1055/s-2004-823098 10.1002/hep.25539 10.1007/BF00280883 10.1053/j.gastro.2007.11.038 10.1001/archinte.163.4.427 10.1093/aje/kwh150 10.1073/pnas.0904944106 10.1136/bmj.d6891 10.1111/j.1440-1746.2006.04698.x 10.3748/wjg.14.2474  | 
    
| ContentType | Journal Article | 
    
| Copyright | Published 2013. This article is a U.S. Government work and is in the public domain in the USA. | 
    
| Copyright_xml | – notice: Published 2013. This article is a U.S. Government work and is in the public domain in the USA. | 
    
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8  | 
    
| DOI | 10.1111/jgh.12106 | 
    
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| EISSN | 1440-1746 | 
    
| EndPage | 670 | 
    
| ExternalDocumentID | 23286209 10_1111_jgh_12106 JGH12106 ark_67375_WNG_XNW0ZD5J_P  | 
    
| Genre | article Research Support, U.S. Gov't, Non-P.H.S Journal Article  | 
    
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KMS LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE ESX WRC WUP AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8  | 
    
| ID | FETCH-LOGICAL-c4296-3683acfc3d53fedc5ab8301858cb151c21a089c9935246513330e10d50a5b5673 | 
    
| IEDL.DBID | DR2 | 
    
| ISSN | 0815-9319 1440-1746  | 
    
| IngestDate | Wed Oct 01 14:07:25 EDT 2025 Mon Jul 21 06:06:06 EDT 2025 Wed Oct 01 02:28:55 EDT 2025 Thu Apr 24 23:09:19 EDT 2025 Wed Jan 22 16:51:33 EST 2025 Sun Sep 21 06:20:08 EDT 2025  | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 4 | 
    
| Language | English | 
    
| License | Published 2013. This article is a U.S. Government work and is in the public domain in the USA. | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c4296-3683acfc3d53fedc5ab8301858cb151c21a089c9935246513330e10d50a5b5673 | 
    
| Notes | ark:/67375/WNG-XNW0ZD5J-P istex:C6A40953873BFB404E9550E89E3C0DC5F18504D9 ArticleID:JGH12106 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23  | 
    
| PMID | 23286209 | 
    
| PQID | 1320167870 | 
    
| PQPubID | 23479 | 
    
| PageCount | 7 | 
    
| ParticipantIDs | proquest_miscellaneous_1320167870 pubmed_primary_23286209 crossref_primary_10_1111_jgh_12106 crossref_citationtrail_10_1111_jgh_12106 wiley_primary_10_1111_jgh_12106_JGH12106 istex_primary_ark_67375_WNG_XNW0ZD5J_P  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | April 2013 | 
    
| PublicationDateYYYYMMDD | 2013-04-01 | 
    
| PublicationDate_xml | – month: 04 year: 2013 text: April 2013  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | Australia | 
    
| PublicationPlace_xml | – name: Australia | 
    
| PublicationTitle | Journal of gastroenterology and hepatology | 
    
| PublicationTitleAlternate | J Gastroenterol Hepatol | 
    
| PublicationYear | 2013 | 
    
| Publisher | Blackwell Publishing Ltd | 
    
| Publisher_xml | – name: Blackwell Publishing Ltd | 
    
| References | Donahue RP, Bean JA, Donahue RD, Goldberg RB, Prineas RJ. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2413-2417. Hanley AJ, Karter AJ, Williams K et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 2005; 112: 3713-3721. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2003; 163: 427-436. Hwang SJ, Lee SD. Hepatic steatosis and hepatitis C: still unhappy bedfellows? J. Gastroenterol. Hepatol. 2011; 26 (Suppl. 1): 96-101. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26: 3153-3159. Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395. Brunt EM. Nonalcoholic steatohepatitis. Semin. Liver Dis. 2004; 24: 3-20. Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 2007; 49: 403-414. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. Lomonaco R, Ortiz-Lopez C, Orsak B et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 2011; 55: 1389-1397. Bambha K, Belt P, Abraham M et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012; 55: 769-780. Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A. In patients with non-alcoholic fatty liver disease (NAFLD), metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 2012. Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850. Lawlor DA, Ebrahim S, May M, Davey SG. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am. J. Epidemiol. 2004; 159: 1013-1018. Martinez-Vizcaino V, Martinez MS, Aguilar FS et al. Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care 2010; 33: 1370-1372. Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008; 196: 696-703. Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U. S. A. 2009; 106: 15430-15435. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186. Hernaez R, Lazo M, Bonekamp S et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090. Hamaguchi M, Kojima T, Takeda N et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005; 143: 722-728. Hsiao PJ, Kuo KK, Shin SJ et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J. Gastroenterol. Hepatol. 2007; 22: 2118-2123. Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig. Dis. 2005; 23: 255-263. Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008; 134: 424-431. Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J. Natl Med. Assoc. 2003; 95: 774, 779-89. Haffner SM, D'Agostino R, Saad MF et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45: 742-748. Lazo M, Hernaez R, Bonekamp S et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891. Tong J, Boyko EJ, Utzschneider KM et al. Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans. Diabetologia 2007; 50: 1156-1160. Pladevall M, Singal B, Williams LK et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 2006; 29: 113-122. Deboer MD, Dong L, Gurka MJ. Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006. Metabolism 2011; 61: 554-561. McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2006; 40 (Suppl. 1): S17-29. Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J. Dig. Dis. 2011; 12: 125-130. Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ. Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World J. Gastroenterol. 2008; 14: 2474-2486. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359. Rafiq N, Younossi ZM. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin. Liver Dis. 2009; 13: 249-266. Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J. Gastroenterol. 2008; 14: 185-192. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 1999; 341: 718-724. Thompson B. Exploratory and Confirmatory Factor Analysis. Washington, DC: American Psychological Association, 2004. 2010; 33 1985; 28 2001; 50 2004; 40 2012 2010 2005; 112 2004; 27 2004; 24 2011; 61 2008; 14 1999; 341 1996 2011; 55 2011; 54 1994 2007; 50 2011; 12 2004 2003; 95 2012; 55 2005; 23 2009; 13 2004; 159 2006; 40 2005; 143 2002; 287 2003; 26 1997; 17 2006; 29 2011; 26 2008; 134 2007; 22 2011; 343 2008; 196 1996; 45 2007; 49 2003; 163 2009; 106 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 Dagogo‐Jack S (e_1_2_6_37_1) 2003; 95 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_16_1 e_1_2_6_42_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_40_1 McCullough AJ (e_1_2_6_7_1) 2006; 40 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_6_1 e_1_2_6_25_1 Younossi ZM (e_1_2_6_34_1) 2012 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1  | 
    
| References_xml | – reference: Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2003; 163: 427-436. – reference: Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26: 3153-3159. – reference: Pladevall M, Singal B, Williams LK et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 2006; 29: 113-122. – reference: Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J. Natl Med. Assoc. 2003; 95: 774, 779-89. – reference: Martinez-Vizcaino V, Martinez MS, Aguilar FS et al. Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care 2010; 33: 1370-1372. – reference: Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359. – reference: Thompson B. Exploratory and Confirmatory Factor Analysis. Washington, DC: American Psychological Association, 2004. – reference: Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U. S. A. 2009; 106: 15430-15435. – reference: Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J. Gastroenterol. 2008; 14: 185-192. – reference: Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J. Dig. Dis. 2011; 12: 125-130. – reference: Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 2007; 49: 403-414. – reference: Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186. – reference: Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ. Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World J. Gastroenterol. 2008; 14: 2474-2486. – reference: Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850. – reference: Brunt EM. Nonalcoholic steatohepatitis. Semin. Liver Dis. 2004; 24: 3-20. – reference: Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008; 196: 696-703. – reference: Hernaez R, Lazo M, Bonekamp S et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090. – reference: Donahue RP, Bean JA, Donahue RD, Goldberg RB, Prineas RJ. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2413-2417. – reference: Hanley AJ, Karter AJ, Williams K et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 2005; 112: 3713-3721. – reference: Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A. In patients with non-alcoholic fatty liver disease (NAFLD), metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 2012. – reference: Deboer MD, Dong L, Gurka MJ. Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006. Metabolism 2011; 61: 554-561. – reference: Lawlor DA, Ebrahim S, May M, Davey SG. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am. J. Epidemiol. 2004; 159: 1013-1018. – reference: McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2006; 40 (Suppl. 1): S17-29. – reference: Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. – reference: Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig. Dis. 2005; 23: 255-263. – reference: Tong J, Boyko EJ, Utzschneider KM et al. Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans. Diabetologia 2007; 50: 1156-1160. – reference: Lomonaco R, Ortiz-Lopez C, Orsak B et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 2011; 55: 1389-1397. – reference: Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008; 134: 424-431. – reference: Lazo M, Hernaez R, Bonekamp S et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891. – reference: Hsiao PJ, Kuo KK, Shin SJ et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J. Gastroenterol. Hepatol. 2007; 22: 2118-2123. – reference: Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 1999; 341: 718-724. – reference: Bambha K, Belt P, Abraham M et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012; 55: 769-780. – reference: Hamaguchi M, Kojima T, Takeda N et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005; 143: 722-728. – reference: Rafiq N, Younossi ZM. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin. Liver Dis. 2009; 13: 249-266. – reference: Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395. – reference: Hwang SJ, Lee SD. Hepatic steatosis and hepatitis C: still unhappy bedfellows? J. Gastroenterol. Hepatol. 2011; 26 (Suppl. 1): 96-101. – reference: Haffner SM, D'Agostino R, Saad MF et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45: 742-748. – volume: 14 start-page: 185 year: 2008 end-page: 192 article-title: Non‐alcoholic fatty liver disease and the metabolic syndrome: an update publication-title: World J. Gastroenterol. – volume: 28 start-page: 412 year: 1985 end-page: 419 article-title: Homeostasis model assessment: insulin resistance and beta‐cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia – year: 2012 article-title: In patients with non‐alcoholic fatty liver disease (NAFLD), metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not publication-title: Metabolism – volume: 159 start-page: 1013 year: 2004 end-page: 1018 article-title: (Mis)use of factor analysis in the study of insulin resistance syndrome publication-title: Am. J. Epidemiol. – volume: 50 start-page: 1844 year: 2001 end-page: 1850 article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome publication-title: Diabetes – volume: 343 start-page: d6891 year: 2011 article-title: Non‐alcoholic fatty liver disease and mortality among US adults: prospective cohort study publication-title: BMJ – volume: 22 start-page: 2118 year: 2007 end-page: 2123 article-title: Significant correlations between severe fatty liver and risk factors for metabolic syndrome publication-title: J. Gastroenterol. Hepatol. – volume: 26 start-page: 3153 year: 2003 end-page: 3159 article-title: The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study publication-title: Diabetes Care – year: 1996 – volume: 23 start-page: 255 year: 2005 end-page: 263 article-title: Clinical syndromes of alcoholic liver disease publication-title: Dig. Dis. – volume: 287 start-page: 356 year: 2002 end-page: 359 article-title: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey publication-title: JAMA – volume: 50 start-page: 1156 year: 2007 end-page: 1160 article-title: Intra‐abdominal fat accumulation predicts the development of the metabolic syndrome in non‐diabetic Japanese‐Americans publication-title: Diabetologia – volume: 40 start-page: S17 year: 2006 end-page: 29 article-title: Pathophysiology of nonalcoholic steatohepatitis publication-title: J. Clin. Gastroenterol. – volume: 17 start-page: 2413 year: 1997 end-page: 2417 article-title: Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 95 start-page: 774 year: 2003 article-title: Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management publication-title: J. Natl Med. Assoc. – volume: 13 start-page: 249 year: 2009 end-page: 266 article-title: Nonalcoholic fatty liver disease: a practical approach to evaluation and management publication-title: Clin. Liver Dis. – volume: 112 start-page: 3713 year: 2005 end-page: 3721 article-title: Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study publication-title: Circulation – year: 1994 – year: 2010 – volume: 143 start-page: 722 year: 2005 end-page: 728 article-title: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease publication-title: Ann. Intern. Med. – volume: 341 start-page: 718 year: 1999 end-page: 724 article-title: A population‐based study of the clinical expression of the hemochromatosis gene publication-title: N. Engl. J. Med. – volume: 61 start-page: 554 year: 2011 end-page: 561 article-title: Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999–2006 publication-title: Metabolism – volume: 163 start-page: 427 year: 2003 end-page: 436 article-title: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994 publication-title: Arch. Intern. Med. – volume: 12 start-page: 125 year: 2011 end-page: 130 article-title: Relationship between nonalcoholic fatty liver disease and metabolic syndrome publication-title: J. Dig. Dis. – year: 2004 – volume: 40 start-page: 1387 year: 2004 end-page: 1395 article-title: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity publication-title: Hepatology – volume: 196 start-page: 696 year: 2008 end-page: 703 article-title: Ethnic differences in the ability of triglyceride levels to identify insulin resistance publication-title: Atherosclerosis – volume: 55 start-page: 1389 year: 2011 end-page: 1397 article-title: Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease publication-title: Hepatology – volume: 26 start-page: 96 issue: Suppl. 1 year: 2011 end-page: 101 article-title: Hepatic steatosis and hepatitis C: still unhappy bedfellows? publication-title: J. Gastroenterol. Hepatol. – volume: 54 start-page: 1082 year: 2011 end-page: 1090 article-title: Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta‐analysis publication-title: Hepatology – volume: 134 start-page: 424 year: 2008 end-page: 431 article-title: Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 33 start-page: 1370 year: 2010 end-page: 1372 article-title: Validity of a single‐factor model underlying the metabolic syndrome in children: a confirmatory factor analysis publication-title: Diabetes Care – volume: 14 start-page: 2474 year: 2008 end-page: 2486 article-title: Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment publication-title: World J. Gastroenterol. – volume: 106 start-page: 15430 year: 2009 end-page: 15435 article-title: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 27 start-page: 1182 year: 2004 end-page: 1186 article-title: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? publication-title: Diabetes Care – volume: 45 start-page: 742 year: 1996 end-page: 748 article-title: Increased insulin resistance and insulin secretion in nondiabetic African‐Americans and Hispanics compared with non‐Hispanic whites. The Insulin Resistance Atherosclerosis Study publication-title: Diabetes – volume: 49 start-page: 403 year: 2007 end-page: 414 article-title: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta‐analysis of longitudinal studies publication-title: J. Am. Coll. Cardiol. – volume: 24 start-page: 3 year: 2004 end-page: 20 article-title: Nonalcoholic steatohepatitis publication-title: Semin. Liver Dis. – volume: 29 start-page: 113 year: 2006 end-page: 122 article-title: A single factor underlies the metabolic syndrome: a confirmatory factor analysis publication-title: Diabetes Care – volume: 55 start-page: 769 year: 2012 end-page: 780 article-title: Ethnicity and nonalcoholic fatty liver disease publication-title: Hepatology – ident: e_1_2_6_28_1 doi: 10.1002/hep.24726 – ident: e_1_2_6_20_1 – ident: e_1_2_6_26_1 – ident: e_1_2_6_2_1 doi: 10.1016/j.jacc.2006.09.032 – ident: e_1_2_6_41_1 doi: 10.1016/j.metabol.2011.09.003 – ident: e_1_2_6_8_1 doi: 10.7326/0003-4819-143-10-200511150-00009 – ident: e_1_2_6_25_1 doi: 10.1161/CIRCULATIONAHA.105.559633 – ident: e_1_2_6_13_1 doi: 10.1016/j.cld.2009.02.009 – year: 2012 ident: e_1_2_6_34_1 article-title: In patients with non‐alcoholic fatty liver disease (NAFLD), metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not publication-title: Metabolism – ident: e_1_2_6_16_1 doi: 10.2337/dc09-2049 – ident: e_1_2_6_18_1 doi: 10.1159/000090173 – volume: 40 start-page: S17 year: 2006 ident: e_1_2_6_7_1 article-title: Pathophysiology of nonalcoholic steatohepatitis publication-title: J. Clin. Gastroenterol. – ident: e_1_2_6_11_1 doi: 10.2337/diabetes.50.8.1844 – ident: e_1_2_6_19_1 doi: 10.1111/j.1440-1746.2010.06542.x – ident: e_1_2_6_38_1 doi: 10.1016/j.atherosclerosis.2006.12.018 – ident: e_1_2_6_3_1 doi: 10.2337/diacare.26.11.3153 – ident: e_1_2_6_4_1 doi: 10.1007/s00125-007-0651-y – ident: e_1_2_6_36_1 doi: 10.2337/diacare.27.5.1182 – ident: e_1_2_6_5_1 doi: 10.1161/01.ATV.17.11.2413 – ident: e_1_2_6_15_1 doi: 10.2337/diacare.29.01.06.dc05-0862 – ident: e_1_2_6_17_1 – ident: e_1_2_6_23_1 doi: 10.1056/NEJM199909023411002 – ident: e_1_2_6_12_1 doi: 10.3748/wjg.14.185 – ident: e_1_2_6_14_1 doi: 10.1037/10694-000 – ident: e_1_2_6_9_1 doi: 10.1111/j.1751-2980.2011.00487.x – ident: e_1_2_6_42_1 doi: 10.1002/hep.24452 – ident: e_1_2_6_39_1 doi: 10.1001/jama.287.3.356 – ident: e_1_2_6_40_1 doi: 10.2337/diab.45.6.742 – volume: 95 start-page: 774 year: 2003 ident: e_1_2_6_37_1 article-title: Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management publication-title: J. Natl Med. Assoc. – ident: e_1_2_6_35_1 doi: 10.1002/hep.20466 – ident: e_1_2_6_24_1 – ident: e_1_2_6_6_1 doi: 10.1055/s-2004-823098 – ident: e_1_2_6_30_1 doi: 10.1002/hep.25539 – ident: e_1_2_6_21_1 doi: 10.1007/BF00280883 – ident: e_1_2_6_31_1 doi: 10.1053/j.gastro.2007.11.038 – ident: e_1_2_6_29_1 doi: 10.1001/archinte.163.4.427 – ident: e_1_2_6_27_1 doi: 10.1093/aje/kwh150 – ident: e_1_2_6_32_1 doi: 10.1073/pnas.0904944106 – ident: e_1_2_6_22_1 doi: 10.1136/bmj.d6891 – ident: e_1_2_6_10_1 doi: 10.1111/j.1440-1746.2006.04698.x – ident: e_1_2_6_33_1 doi: 10.3748/wjg.14.2474  | 
    
| SSID | ssj0004075 | 
    
| Score | 2.4236646 | 
    
| Snippet | Background and Aim
The metabolic syndrome (MetS) and each of its components are strongly associated with non‐alcoholic fatty liver disease (NAFLD). This has... The metabolic syndrome (MetS) and each of its components are strongly associated with non-alcoholic fatty liver disease (NAFLD). This has led many...  | 
    
| SourceID | proquest pubmed crossref wiley istex  | 
    
| SourceType | Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 664 | 
    
| SubjectTerms | Adult Cross-Sectional Studies factor analysis Factor Analysis, Statistical Fatty Liver - diagnostic imaging Fatty Liver - etiology Female Health Surveys Humans insulin resistance Male Metabolic Syndrome - complications Metabolic Syndrome - diagnostic imaging Middle Aged NAFLD Non-alcoholic Fatty Liver Disease Nutrition Surveys obesity Prevalence Regression Analysis Sensitivity and Specificity Ultrasonography United States - epidemiology  | 
    
| Title | Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups | 
    
| URI | https://api.istex.fr/ark:/67375/WNG-XNW0ZD5J-P/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.12106 https://www.ncbi.nlm.nih.gov/pubmed/23286209 https://www.proquest.com/docview/1320167870  | 
    
| Volume | 28 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0815-9319 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1440-1746 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004075 providerName: Wiley-Blackwell  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqVqq4QCmvpRQNCCEuqfJYJ1l6qoB2tVJXqLDqCiFZtuN0qy7ZauMg2hM_gQt_kF_CjPOAoiIhbjmMLSf-Jv7GHn_D2LNBnuWk-eLJJFReP1HSUzyVXuKT9joG0EFO-x2H43g46Y-mfLrCdtu7MLU-RLfhRp7h_tfk4FKVvzv5yYykEZzcdhDFLpw6-iUd1a9FdnHF494AcdaoCrksnrbllbVojT7rl-uI5lXe6hae_VvsYzvkOt_kbKeyakdf_qHm-J_vtMFuNoQU9moE3WYrpthk64fNkfsd9n28KH58_SbrUrqnGnJp7QXMKZ8DmuMdkCXIAk67kroWSFYjN2V90A-LHJBowidjEXPUSSuU8BKOTFnNbUkmEibvoN2dhLJafjYX2Ck2XRoDxs4KbOmuoZR32WT_zftXQ6-p5eBpXPFiL4rTSOpcRxmPcpNpLlWKQEh5qhWSDh0G0k8HGtkSD6k8O8HEBH7GfckVj5PoHlstFoV5wICHcdaXkclITFD5WZrg9JooRCqHwapMe-xFO6tCN0LnVG9jLrqA52Qm3Gfusaed6Xmt7nGd0XMHjc5CLs8oHS7h4nh8IKbjY__Daz4Sb3vsSYsdgU5KJy-yMIuqFHRPPYjp39hj92tQdb0hpcWo0h_gsB00_j4QMToYuoeH_266xW6EroAH5Ro9Yqt2WZltpFFWPXb-8hM0ARgb | 
    
| linkProvider | Wiley-Blackwell | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB1VrQRcoHy1CwUMQohLqmwSJ1nEBQHtsnQjVLrqCglZtuN0qy5ZtEkQ5cRP4MIf5Jcw43xAUZEQtxzGlmO_sZ_t8RuAh4MszUjzxZGRp5wgUtJRPJZO5JL2Om6g-xmdd4yTcDgJRlM-XYGn7VuYWh-iO3Ajz7DzNTk4HUj_7uVHM9JGIL3ttSDEfQpRov1f4lFBLbOLax53Boi0RlfIxvG0Rc-sRmvUsZ_Po5pnmatdenauwPu20XXEycl2Vapt_eUPPcf__at1uNxwUvasBtFVWDH5Nbgwbm7dr8P3ZJH_-PpN1tl0jzXLZFmesjmFdLDmhofJgsmcHXdZdUtGyhqZKeq7frbIGHJN9sGUCDuqpNVKeML2TVHNy4JMJJu8Ze0BJSuq5SdzipVi0aUxzJSzHEvalyjFDZjsvDx4PnSadA6OxkUvdPww9qXOtJ9yPzOp5lLFiIWYx1oh79BeX7rxQCNh4h5laCekmL6bcldyxcPIvwmr-SI3m8C4F6aB9E1KeoLKTeMIx9f4HrI5xIGMe_C4HVahG61zSrkxF92e52gmbDf34EFn-rEW-DjP6JHFRmchlycUERdxcZjsimly6L57wUfiTQ_ut-AR6Kd0-SJzs6gKQU_V-yFNjz3YqFHV1YasFjeW7gCbbbHx94aI0e7Qftz6d9N7cHF4MN4Te6-S17fhkmfzeVDo0RaslsvK3EFWVaq71nl-ArJpHDw | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWqVqrYQHkPFDAIITapMkmcR8UGMUyHgUZVYdRRJWQ5jt2pOmSqiVNRVnwCG36QL-Fe5wFFRULssri2HPtc-9i-PpeQp4nONWq-OCLyMieIMuFkLBZO5KL2Omyg-xrPO3bTcDQJxlM2XSEv2rcwtT5Ed-CGnmHna3RwdZrr3738aIbaCKi3vRawJMaAvsH-L_GooJbZhTWPOQkgrdEVsnE8bdELq9Eaduzny6jmReZql57hNfKxbXQdcXKyVZlsS375Q8_xf_9qg1xtOCl9WYPoOllRxQ2yvtvcut8k39NF8ePrN1Fn0z2WVAtjzukcQzpoc8NDRUlFQY-7rLqGorKGVmV9108XmgLXpJ-UAdhhJa1WwjbdV2U1NyWaCDp5T9sDSlpWyzN1DpVC0aVSVJlZASXtS5TyFpkMX394NXKadA6OhEUvdPww9oXU0s-Zr1UumchiwELMYpkB75BeX7hxIoEwMQ8ztCNSVN_NmStYxsLIv01Wi0Wh7hLKvDAPhK9y1BPM3DyOYHyV7wGbg_2qiHvkeTusXDZa55hyY867Pc_RjNtu7pEnnelpLfBxmdEzi43OQixPMCIuYvwg3eHT9MA9HLAx3-uRxy14OPgpXr6IQi2qkuNT9X6I02OP3KlR1dUGrBY2lm4CzbbY-HtD-HhnZD_u_bvpI7K-Nxjyd2_St_fJFc-m88DIo02yapaVegCkymQPre_8BDR2G8A | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non%E2%80%90alcoholic+fatty+liver+disease+as+an+independent+manifestation+of+the+metabolic+syndrome%3A+Results+of+a+US+national+survey+in+three+ethnic+groups&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Smits%2C+Mark+M&rft.au=Ioannou%2C+George+N&rft.au=Boyko%2C+Edward+J&rft.au=Utzschneider%2C+Kristina+M&rft.date=2013-04-01&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=28&rft.issue=4&rft.spage=664&rft.epage=670&rft_id=info:doi/10.1111%2Fjgh.12106&rft.externalDBID=10.1111%252Fjgh.12106&rft.externalDocID=JGH12106 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon |